IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Finepoint Capital LP

Q4 2023 Holdings

Filed 2024-02-13 | 27 holdings | $317.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$36.0M431,69311.4%
Spirit Airlines Inc(SAVEEUR)CallCOM848577102$27.9M1,700,0008.8%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$24.1M769,6537.6%
Amicus Therapeutics Inc(FOLD)COM03152W109$21.1M1,489,0256.7%
Arvinas Inc(ARVN)COM04335A105$20.8M504,7006.6%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$20.6M163,7726.5%
Springworks Therapeutics IncCOM85205L107$20.3M556,9286.4%
Home Plate Acquisition Corp*W EXP 09/30/20243734R111$20.0M331,4166.3%
Galapagos NV(GLPG)SPON ADR36315X101$18.6M458,6595.9%
Revolution Medicines Inc(RVMD)COM76155X100$17.7M617,1005.6%
Liberty Broadband Corp(LBRDK)COM SER C530307305$14.9M184,4604.7%
Relay Therapeutics Inc(RLAY)COM75943R102$14.5M1,317,8704.6%
Morphic Holding IncCOM61775R105$14.3M496,8564.5%
Sarepta Therapeutics Inc(SRPT)COM803607100$14.0M145,3574.4%
Travere Therapeutics Inc(TVTX)COM89422G107$12.9M1,435,3214.1%
Prothena Corp PLC(PRTA)SHSG72800108$12.7M349,3004.0%
Solid Biosciences Inc(SLDB)COM NEW83422E204$5.9M961,2511.9%
Calidi Biotherapeutics IncCOM NEW320703101$188.8K125,0000.1%
Churchill Capital Corp VII*W EXP 02/29/20217144M110$71.3K548,0000.0%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$62.7K895,0000.0%
Concord Acquisition Corp II*W EXP 99/99/99920607U116$53.1K408,3330.0%
Calidi Biotherapeutics Inc*W EXP 03/14/202320703119$32.8K655,2000.0%
Ross Acquisition Corp II*W EXP 02/01/202G7641C114$24.6K439,6660.0%
Compass Digital Acquisition Corp(COMP)*W EXP 09/29/202G2476C123$22.3K459,9060.0%
Marblegate Acquisition Corp*W EXP 08/31/20256608A113$22.1K735,0000.0%
Swiftmerge Acquisition Corp*W EXP 12/13/202G63836111$20.1K490,0000.0%
YS Biopharma Co LTD*W EXP 03/15/202G9845F117$13.3K489,9990.0%